ArticleJournal of translational medicine2019

Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.

Gaetano Facchini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.